ABSTRACT: The Current Treatment of Ductal Carcinoma in Situ
A consensus conference was held in April, 1999, to help sift through
the maze of controversy surrounding the treatment of mammographically
detected ductal carcinoma in situ (DCIS). Members of the panel
included approximately 30 DCIS experts, who addressed issues
relating diagnosis, treatment, treatment of breast (and axilla),
adjuvant theraphy, among others. The panel agreed that the goal
of treatment for DCIS is breast conservation and attempted to
divide the population of patients with DCIS into subsets who
are appropriately treated by mastectomy, radiation theraphy,
or by excision alone. Major criteria for breast conservation
include small size of area of DCIS, clear surgical margins, and
Neither axilliary dissection nor sentinel
node biopsy is appropriate for DCIS treated by breast conservation.
The role of tamoxifen is currently under study, and although
approved by the FDA for "risk reduction," its use in patients
with DCIS is uncertain.
[01/07/2002; The Breast Journal]
Annals of Surg Onc, 12/02
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.